Evidence map›Paper›PMID 30295509›Full record

ArticleDiabetes & vascular disease research2019

Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries.

Romana S Mughal, Katherine Bridge, Irma Buza, Rita Slaaby, Jesper Worm, Gro Klitgaard-Povlsen, Henning Hvid, Marianne Schiødt, Richard Cubbon, Nadira Yuldasheva and 4 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Diabetes & vascular disease research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. IGF-1R targeting in cancer - does sub-cellular localization matter?Journal of experimental & clinical cancer research : CR · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Romana S Mughal1 Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0002-9101-8905
Katherine Bridge1 Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds, UK.
Irma Buza2 Global Research, Novo Nordisk A/S, Malov, Denmark.
Rita Slaaby2 Global Research, Novo Nordisk A/S, Malov, Denmark.
Jesper Worm2 Global Research, Novo Nordisk A/S, Malov, Denmark.
Gro Klitgaard-Povlsen2 Global Research, Novo Nordisk A/S, Malov, Denmark.
Henning Hvid2 Global Research, Novo Nordisk A/S, Malov, Denmark.
Marianne Schiødt2 Global Research, Novo Nordisk A/S, Malov, Denmark.
Richard Cubbon1 Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds, UK.
Nadira Yuldasheva1 Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds, UK.
Anna Skromna1 Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds, UK.
Natallia Makava1 Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds, UK.
Grith Skytte-Olsen2 Global Research, Novo Nordisk A/S, Malov, Denmark.
Mark T Kearney1 Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), School of Medicine, University of Leeds, Leeds, UK.
Novo Nordisk (Denmark) · DKUniversity of Leeds · GB

Funding

British Heart Foundation FS/12/80/29821
6 · The paper itself

Abstract

Insulin and insulin-like growth factor-1 stimulate specific responses in arteries, which may be disrupted by diet-induced obesity. We examined (1) temporal effects of high-fat diet compared to low-fat diet in mice on insulin receptor, insulin-like growth factor-1 receptor, insulin receptor/insulin-like growth factor-1 receptor hybrid receptor expression and insulin/insulin-like growth factor-1-mediated Akt phosphorylation in aorta; and (2) effects of high-fat diet on insulin and insulin-like growth factor-1-mediated Akt phosphorylation and vascular tone in resistance arteries. Medium-term high-fat diet (5 weeks) decreased insulin-like growth factor-1 receptor expression and increased hybrid expression (~30%) only. After long-term (16 weeks) high-fat diet, insulin receptor expression was reduced by ~30%, insulin-like growth factor-1 receptor expression decreased a further ~40% and hybrid expression increased a further ~60%. Independent correlates of hybrid receptor expression were high-fat diet, duration of high-fat diet and plasma insulin-like growth factor-1 (all p < 0.05). In aorta, insulin was a more potent activator of Akt than insulin-like growth factor-1, whereas in resistance arteries, insulin-like growth factor-1 was more potent than insulin. High-fat diet blunted insulin-mediated vasorelaxation ( p < 0.01) but had no effect on insulin-like growth factor-1-mediated vasorelaxation in resistance arteries. Our findings support the possibility that hybrid receptor level is influenced by nutritional and metabolic cues. Moreover, vessel-dependent effects of insulin and insulin-like growth factor-1 on vascular tone and Akt activation may have implications in treating obesity-related vascular disease.

Indexed as

AnimalsAntigens, CDAortaCells, CulturedDiet, Fat-RestrictedDiet, High-FatDisease Models, AnimalEnzyme ActivationHumansHuman Umbilical Vein Endothelial CellsInsulinInsulin-Like Growth Factor IMaleMesenteric ArteriesMice, Inbred C57BLObesityAntigens, CDIGF1 protein, humanIGF1R protein, humanIgf1r protein, mouseINSR protein, humanInsulinInsulin-Like Growth Factor IProto-Oncogene Proteins c-aktReceptor, IGF Type 1Receptor, InsulinReceptors, Somatomedinhybrid receptorsIGF-1 receptorsObesity

Identifiers

PMID30295509
PMCPMC6484231
OpenAlexW2890544773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.